NeuroMetrix Reports Quell® Technology to be Used in NIH-Funded Trial Evaluating Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS) for Fibromyalgia
![GlobeNewswire](../../../Content/images/providers/GN.png)
NeuroMetrix, Inc. (NURO)
Last neurometrix, inc. earnings: 4/20 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.neurometrix.com/investor-relations
Company Research
Source: GlobeNewswire
WOBURN, Mass., April 16, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that Quell technology has been selected for use in a large, NIH-funded, randomized, pragmatic clinical trial of TENS for fibromyalgia. Fibromyalgia is a disorder characterized by widespread musculoskeletal pain accompanied by fatigue, sleep and mood disturbances. It affects an estimated 2 to 4 percent of the US population, or as many as 6 to 12 million people, and is most often diagnosed between the ages of 30 and 50. The cause of fibromyalgia remains unclear, but scientific studies point to abnormalities in the way the brain processes normal sensations and pain. Although several drugs are approved for treating fibromyalgia pain, there is an unmet need for safe, non-pharmacological options. TENS is a non-invasive pain relief approach. In a recently published sham-controlled, double-blind, randomized controlled trial (RCT), TENS using frequency and charge modulated pulses was sho
Show less
Read more
Impact Snapshot
Event Time:
NURO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NURO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NURO alerts
High impacting NeuroMetrix, Inc. news events
Weekly update
A roundup of the hottest topics
NURO
News
- NeuroMetrix, Inc. (NASDAQ: NURO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- NeuroMetrix, Inc. (NASDAQ: NURO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- NeuroMetrix, Inc. (NASDAQ: NURO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- NeuroMetrix Reiterates its Review of Strategic Alternatives [Yahoo! Finance]Yahoo! Finance
- NeuroMetrix Reiterates its Review of Strategic AlternativesGlobeNewswire
NURO
Sec Filings
- 8/6/24 - Form 10-Q
- 8/6/24 - Form 8-K
- NURO's page on the SEC website